Legal Representation
Attorney
Neil F Greenblum
USPTO Deadlines
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 29, 2004 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 29, 2004 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Aug 5, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Apr 26, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 18, 2004 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jan 28, 2004 | I | PAPER RECEIVED | Loading... | |
| Jan 28, 2004 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 19, 2003 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 21, 2003 | I | PAPER RECEIVED | Loading... | |
| Jul 21, 2003 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 4, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 29, 2003 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 12, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 23, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Aug 21, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 15, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Jun 12, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Jun 10, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 23, 2002 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Apr 18, 2002 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Mar 5, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 22, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Sep 19, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 19, 2001 | 44DD | I | SEC. 44(D) CLAIM DELETED | Loading... |
| Apr 2, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Mar 26, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases, and cancer; products with a therapeutical advantage, namely, propolis for medicinal or therapeutic purposes; topical gel for medical and therapeutic use for the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases, and cancer; diagnosis and prognosis products for medical use, namely, diagnostic reagents for clinical or medical laboratory use; medication for human medicine, namely, cytokines growth factors, therapeutic proteins, and monoclonal antibodies for use in the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Class 016
Instruction manuals in the field of chemistry, biology and biotechnology and genetics, computer instruction manuals sold separately, educational and reference books in the area of chemistry, biology, biotechnology and genetics, printed publication in the nature of printed reviews of pharmaceutical and diagnostic applications and genetic applications, newspapers of pharmaceutical and diagnostic application and genetic applications
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Computerized database management
First Use Anywhere:
0
First Use in Commerce:
0
Class 038
Electronic transmission of data and documents via computer terminals, providing multiple-user access to a global computer information network, electronic transmission of data and documents via computer terminals, namely, broadcasting information via the worldwide communication networks, the Internet, and via restricted access Intranet networks
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Medical services, scientific research, medical and scientific diagnosis an analysis in the field of physical therapy, chemical and biological analysis, research in chemistry and biology, structural and functional analysis of genomes, conducting feasibility studies, namely, conducting studies in technical projects, product research and development, namely, developmental research studies in technical projects, developmental research of new products for third parties, technical assistance
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
Color is claimed as a feature of the mark. The letters "Gen" are blue and the letters "dyssee" are gray. The upper half of the circle design is light gray and the lower half of the circle design is dark gray. The design surrounding the circle design is blue with red, yellow and dark blue dots.
Other
The lining is a feature of the mark and does not indicate color.
Classification
International Classes
005
016
035
038
042